middle.news
How Atomo’s US Supply Deal and Syphilis Test Could Transform Diagnostics
9:58am on Tuesday 29th of July, 2025 AEST
•
Healthcare
Read Story
How Atomo’s US Supply Deal and Syphilis Test Could Transform Diagnostics
9:58am on Tuesday 29th of July, 2025 AEST
Key Points
Exclusive six-year US supply deal for Pascal FebriDx via Lumos Diagnostics
Australian HIV Self-Test sales surge 143% year-on-year to $1.4 million
Positive preliminary data for Active Syphilis test improves diagnostic specificity
Board renewal completed with two new directors experienced in point-of-care diagnostics
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Atomo Diagnostics (ASX:AT1)
OPEN ARTICLE